These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 8435843)
21. [Research in the field of substances with antiviral action. Derivatives of nitrothienyl- and nitropyrrolylglyoxyals]. Riccieri FM; Gualtieri F; Babudieri B Farmaco Sci; 1965 Oct; 20(10):707-20. PubMed ID: 5882349 [No Abstract] [Full Text] [Related]
22. Drug repurposing for new, efficient, broad spectrum antivirals. García-Serradilla M; Risco C; Pacheco B Virus Res; 2019 Apr; 264():22-31. PubMed ID: 30794895 [TBL] [Abstract][Full Text] [Related]
23. Antivirals of ethnomedicinal origin: structure-activity relationship and scope. Chattopadhyay D; Naik TN Mini Rev Med Chem; 2007 Mar; 7(3):275-301. PubMed ID: 17346219 [TBL] [Abstract][Full Text] [Related]
24. Antiviral Potential of Algae Polysaccharides Isolated from Marine Sources: A Review. Ahmadi A; Zorofchian Moghadamtousi S; Abubakar S; Zandi K Biomed Res Int; 2015; 2015():825203. PubMed ID: 26484353 [TBL] [Abstract][Full Text] [Related]
25. Development of antiviral agents for enteroviruses. Chen TC; Weng KF; Chang SC; Lin JY; Huang PN; Shih SR J Antimicrob Chemother; 2008 Dec; 62(6):1169-73. PubMed ID: 18931391 [TBL] [Abstract][Full Text] [Related]
26. The past, present and future of antiviral drug discovery. Littler E IDrugs; 2004 Dec; 7(12):1104-12. PubMed ID: 15599804 [TBL] [Abstract][Full Text] [Related]
32. Antivirals in the transplant setting. Griffiths PD Antiviral Res; 2006 Sep; 71(2-3):192-200. PubMed ID: 16793148 [TBL] [Abstract][Full Text] [Related]
33. Cytomegalovirus (CMV) resistance to antivirals. Drew WL; Paya CV; Emery V Am J Transplant; 2001 Nov; 1(4):307-12. PubMed ID: 12099372 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and antiviral activity of new pyrazole and thiazole derivatives. el-Sabbagh OI; Baraka MM; Ibrahim SM; Pannecouque C; Andrei G; Snoeck R; Balzarini J; Rashad AA Eur J Med Chem; 2009 Sep; 44(9):3746-53. PubMed ID: 19419804 [TBL] [Abstract][Full Text] [Related]
35. The design of drugs for HIV and HCV. De Clercq E Nat Rev Drug Discov; 2007 Dec; 6(12):1001-18. PubMed ID: 18049474 [TBL] [Abstract][Full Text] [Related]
36. Overview on the antiviral activities and mechanisms of marine polysaccharides from seaweeds. Shi Q; Wang A; Lu Z; Qin C; Hu J; Yin J Carbohydr Res; 2017 Dec; 453-454():1-9. PubMed ID: 29102716 [TBL] [Abstract][Full Text] [Related]
37. Strategies for antiviral drug discovery. Jones PS Antivir Chem Chemother; 1998 Jul; 9(4):283-302. PubMed ID: 9875408 [TBL] [Abstract][Full Text] [Related]
38. Sulfated K5 Escherichia coli polysaccharide derivatives: A novel class of candidate antiviral microbicides. Rusnati M; Vicenzi E; Donalisio M; Oreste P; Landolfo S; Lembo D Pharmacol Ther; 2009 Sep; 123(3):310-22. PubMed ID: 19447134 [TBL] [Abstract][Full Text] [Related]
39. Editorial overview: Antiviral strategies: Antiviral drug design: creating new ideas against old and new bugs. Naesens L; Zoulim F Curr Opin Virol; 2017 Jun; 24():v-vii. PubMed ID: 28743435 [No Abstract] [Full Text] [Related]
40. Nucleic-acid-based antiviral agents against positive single-stranded RNA viruses. Lim TW; Yuan J; Liu Z; Qiu D; Sall A; Yang D Curr Opin Mol Ther; 2006 Apr; 8(2):104-7. PubMed ID: 16610761 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]